Last month, on the basis of an appeal dated 03/06/2023 from the Operational-Investigative Main Department of the State Customs Committee of the Republic of Azerbaijan to the Analytical Expertise Center, samples of “Lipotrim kaps N36” (serial number: 555017, expiration date: 03/01/2023) and “ Black Panther kaps N36″ (series: 0000991720, expiration date: 02/01/2025) were examined.
As a result of studies conducted on the presented samples under the names “Lipotrim kaps N36” and “Black Panther kaps N36”, the identity of the active substance under the name “sibutramine” was established, which was not indicated on the package and at the same time was included in the list of “Highly active substances and their total number”, approved by the Law of the Republic of Azerbaijan dated March 18, 2016.
It should be noted that there was no appeal “Lipotrim Capsules N36” and “Black Panther Caps N36” to the CAE for the examination of FS.
It should be noted that Sibutramine, an anorexigenic substance that enhances the feeling of satiety, is a derivative of amphetamine. Belongs to a group of medicines used to treat obesity, and is used in the complex maintenance therapy of overweight patients. The use of sibutramine in the European Union was suspended in 2010 after the results of studies by the European Medicines Agency on the risks of side effects of subitramine-containing medicines.
The FDA also required manufacturers to state on the product label that sibutramine is prohibited for use in patients with cardiovascular disease. In addition, sibutramine is included in the list of prohibited substances by the World Anti-Doping Agency.
